Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

Abramson Cancer Center at Penn Medicine

Status: Completed

Conditions: BRCA1/2 Negative

Treatments: Other: Questionnaires

Study type: Interventional

Funder types: Other

Identifiers

NCT02514499

UPCC 07914

Details and patient eligibility

About

The overall goal of the proposed research is to evaluate the uptake of testing and longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2 negative patients. This model will inform the selection of the outcomes and potential mediators and moderators of these outcomes, to inform the debate over utility, risks, and benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. Women and men (at least 18 YO) 2. English speaking AND 3. Negative for BRCA1 and BRCA2 mutations

Exclusion criteria

1. Non English speaking patients